MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin
► Overexpression of miR-203 inhibits laryngeal cancer cell proliferation. ► Survivin is a direct target of miR-203 in laryngeal cancer cells. ► Survivin plays a critical role in miR-203-induced G1 phase cell cycle arrest. ► Survivin mRNA inversely correlates with miR-203 in human laryngeal carcinoma...
Gespeichert in:
Veröffentlicht in: | FEBS letters 2012-03, Vol.586 (6), p.804-809 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | ► Overexpression of miR-203 inhibits laryngeal cancer cell proliferation. ► Survivin is a direct target of miR-203 in laryngeal cancer cells. ► Survivin plays a critical role in miR-203-induced G1 phase cell cycle arrest. ► Survivin mRNA inversely correlates with miR-203 in human laryngeal carcinoma.
Previous studies have shown that miR-203 acts as a tumor-suppressive microRNA in various cancers, but its roles in laryngeal carcinoma are still contradicted. Here, we found that miR-203 inhibited the growth of laryngeal cancer cells and survivin was a direct target of miR-203. Moreover, silencing of survivin recapitulated the effect of miR-203 on cell cycle progression, whereas overexpression of survivin reversed this effect. Additionally, qRT-PCR showed the reciprocal relationship between miR-203 and survivin in laryngeal cancer tissues. These findings indicate that miR-203 inhibits the proliferation of laryngeal carcinoma cells by directly targeting survivin, suggesting its application in anti-cancer therapeutics. |
---|---|
ISSN: | 0014-5793 1873-3468 |
DOI: | 10.1016/j.febslet.2012.01.050 |